ArticleCancer science2025
Distribution of Ectopic Germinal Centers in Thymic Epithelial Tumors and Their Relationship With Thymic Involution.
Article in Cancer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pathobiology of thymic epithelial tumours and the treatment strategy based on immuno-oncological characteristics: a narrative review.Mediastinum (Hong Kong, China) · 2026Review
- Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study.ImmunoTargets and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Ectopic germinal centers (GCs) are often formed in the thymus of patients with anti-acetylcholine receptor antibody (anti-AChR Ab)-positive thymic epithelial tumors (TETs) and are considered sites where B cells undergo affinity maturation to produce high-affinity anti-AChR Abs, contributing to the development of myasthenia gravis. To evaluate the clinical relevance of these ectopic GCs, we analyzed their distribution and associations with thymic involution and anti-AChR Ab titers using paraffin-embedded surgical specimens from 79 TET patients. Thymic involution was scored, and immunohistochemistry was performed to identify cells involved in GC formation. GCs were identified in 32 of the 79 cases. The anti-AChR Ab+ group had significantly higher frequencies of GCs in the residual thymus compared to the Ab- group. In all cases with GCs in the residual thymus, GCs were found both near the tumor and at distances greater than 1 cm from the tumor. Within the anti-AChR Ab+ group, GC+ patients were significantly younger and showed milder thymic involution than GC- patients. The number of GCs per unit area positively correlated with serum antibody titer. In Ab+ cases, AChR-α1 antigens were significantly more frequent in GC+ cases. In mildly involuted thymus, AChR antigens, antigen-presenting cells, and B cells were detected in the medulla, whereas these were rarely observed in severely involuted thymus. These findings suggest that GC formation occurs preferentially in a less involuted thymus and that surgical resection of at least the extent of a total thymectomy may be indicated in younger patients with anti-AChR Ab+ TETs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.